2024-04-01 2025-03-31 2025-03-31 false 09430446 RICHMOND DENTAL SUITE LIMITED 2026-03-10 false iso4217:GBP xbrli:pure 09430446 2024-03-31 09430446 2025-03-31 09430446 2024-04-01 2025-03-31 09430446 2023-03-31 09430446 2024-03-31 09430446 2023-04-01 2024-03-31 09430446 bus:SmallEntities 2024-04-01 2025-03-31 09430446 bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 09430446 bus:FullAccounts 2024-04-01 2025-03-31 09430446 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 09430446 core:WithinOneYear 2025-03-31 09430446 core:AfterOneYear 2025-03-31 09430446 core:WithinOneYear 2024-03-31 09430446 core:AfterOneYear 2024-03-31 09430446 core:ShareCapital 2025-03-31 09430446 core:SharePremium 2025-03-31 09430446 core:RevaluationReserve 2025-03-31 09430446 core:OtherReservesSubtotal 2025-03-31 09430446 core:RetainedEarningsAccumulatedLosses 2025-03-31 09430446 core:ShareCapital 2024-03-31 09430446 core:SharePremium 2024-03-31 09430446 core:RevaluationReserve 2024-03-31 09430446 core:OtherReservesSubtotal 2024-03-31 09430446 core:RetainedEarningsAccumulatedLosses 2024-03-31 09430446 core:LandBuildings 2025-03-31 09430446 core:PlantMachinery 2025-03-31 09430446 core:Vehicles 2025-03-31 09430446 core:FurnitureFittings 2025-03-31 09430446 core:OfficeEquipment 2025-03-31 09430446 core:NetGoodwill 2025-03-31 09430446 core:IntangibleAssetsOtherThanGoodwill 2025-03-31 09430446 core:ListedExchangeTraded 2025-03-31 09430446 core:UnlistedNon-exchangeTraded 2025-03-31 09430446 core:LandBuildings 2024-03-31 09430446 core:PlantMachinery 2024-03-31 09430446 core:Vehicles 2024-03-31 09430446 core:FurnitureFittings 2024-03-31 09430446 core:OfficeEquipment 2024-03-31 09430446 core:NetGoodwill 2024-03-31 09430446 core:IntangibleAssetsOtherThanGoodwill 2024-03-31 09430446 core:ListedExchangeTraded 2024-03-31 09430446 core:UnlistedNon-exchangeTraded 2024-03-31 09430446 core:LandBuildings 2024-04-01 2025-03-31 09430446 core:PlantMachinery 2024-04-01 2025-03-31 09430446 core:Vehicles 2024-04-01 2025-03-31 09430446 core:FurnitureFittings 2024-04-01 2025-03-31 09430446 core:OfficeEquipment 2024-04-01 2025-03-31 09430446 core:NetGoodwill 2024-04-01 2025-03-31 09430446 core:IntangibleAssetsOtherThanGoodwill 2024-04-01 2025-03-31 09430446 core:ListedExchangeTraded 2024-04-01 2025-03-31 09430446 core:UnlistedNon-exchangeTraded 2024-04-01 2025-03-31 09430446 core:MoreThanFiveYears 2024-04-01 2025-03-31 09430446 core:Non-currentFinancialInstruments 2025-03-31 09430446 core:Non-currentFinancialInstruments 2024-03-31 09430446 dpl:CostSales 2024-04-01 2025-03-31 09430446 dpl:DistributionCosts 2024-04-01 2025-03-31 09430446 core:LandBuildings 2024-04-01 2025-03-31 09430446 core:PlantMachinery 2024-04-01 2025-03-31 09430446 core:Vehicles 2024-04-01 2025-03-31 09430446 core:FurnitureFittings 2024-04-01 2025-03-31 09430446 core:OfficeEquipment 2024-04-01 2025-03-31 09430446 dpl:AdministrativeExpenses 2024-04-01 2025-03-31 09430446 core:NetGoodwill 2024-04-01 2025-03-31 09430446 core:IntangibleAssetsOtherThanGoodwill 2024-04-01 2025-03-31 09430446 dpl:GroupUndertakings 2024-04-01 2025-03-31 09430446 dpl:ParticipatingInterests 2024-04-01 2025-03-31 09430446 dpl:GroupUndertakings core:ListedExchangeTraded 2024-04-01 2025-03-31 09430446 core:ListedExchangeTraded 2024-04-01 2025-03-31 09430446 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2024-04-01 2025-03-31 09430446 core:UnlistedNon-exchangeTraded 2024-04-01 2025-03-31 09430446 dpl:CostSales 2023-04-01 2024-03-31 09430446 dpl:DistributionCosts 2023-04-01 2024-03-31 09430446 core:LandBuildings 2023-04-01 2024-03-31 09430446 core:PlantMachinery 2023-04-01 2024-03-31 09430446 core:Vehicles 2023-04-01 2024-03-31 09430446 core:FurnitureFittings 2023-04-01 2024-03-31 09430446 core:OfficeEquipment 2023-04-01 2024-03-31 09430446 dpl:AdministrativeExpenses 2023-04-01 2024-03-31 09430446 core:NetGoodwill 2023-04-01 2024-03-31 09430446 core:IntangibleAssetsOtherThanGoodwill 2023-04-01 2024-03-31 09430446 dpl:GroupUndertakings 2023-04-01 2024-03-31 09430446 dpl:ParticipatingInterests 2023-04-01 2024-03-31 09430446 dpl:GroupUndertakings core:ListedExchangeTraded 2023-04-01 2024-03-31 09430446 core:ListedExchangeTraded 2023-04-01 2024-03-31 09430446 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2023-04-01 2024-03-31 09430446 core:UnlistedNon-exchangeTraded 2023-04-01 2024-03-31 09430446 core:NetGoodwill 2025-03-31 09430446 core:IntangibleAssetsOtherThanGoodwill 2025-03-31 09430446 core:LandBuildings 2025-03-31 09430446 core:PlantMachinery 2025-03-31 09430446 core:Vehicles 2025-03-31 09430446 core:FurnitureFittings 2025-03-31 09430446 core:OfficeEquipment 2025-03-31 09430446 core:AfterOneYear 2025-03-31 09430446 core:WithinOneYear 2025-03-31 09430446 core:ListedExchangeTraded 2025-03-31 09430446 core:UnlistedNon-exchangeTraded 2025-03-31 09430446 core:ShareCapital 2025-03-31 09430446 core:SharePremium 2025-03-31 09430446 core:RevaluationReserve 2025-03-31 09430446 core:OtherReservesSubtotal 2025-03-31 09430446 core:RetainedEarningsAccumulatedLosses 2025-03-31 09430446 core:NetGoodwill 2024-03-31 09430446 core:IntangibleAssetsOtherThanGoodwill 2024-03-31 09430446 core:LandBuildings 2024-03-31 09430446 core:PlantMachinery 2024-03-31 09430446 core:Vehicles 2024-03-31 09430446 core:FurnitureFittings 2024-03-31 09430446 core:OfficeEquipment 2024-03-31 09430446 core:AfterOneYear 2024-03-31 09430446 core:WithinOneYear 2024-03-31 09430446 core:ListedExchangeTraded 2024-03-31 09430446 core:UnlistedNon-exchangeTraded 2024-03-31 09430446 core:ShareCapital 2024-03-31 09430446 core:SharePremium 2024-03-31 09430446 core:RevaluationReserve 2024-03-31 09430446 core:OtherReservesSubtotal 2024-03-31 09430446 core:RetainedEarningsAccumulatedLosses 2024-03-31 09430446 core:NetGoodwill 2023-03-31 09430446 core:IntangibleAssetsOtherThanGoodwill 2023-03-31 09430446 core:LandBuildings 2023-03-31 09430446 core:PlantMachinery 2023-03-31 09430446 core:Vehicles 2023-03-31 09430446 core:FurnitureFittings 2023-03-31 09430446 core:OfficeEquipment 2023-03-31 09430446 core:AfterOneYear 2023-03-31 09430446 core:WithinOneYear 2023-03-31 09430446 core:ListedExchangeTraded 2023-03-31 09430446 core:UnlistedNon-exchangeTraded 2023-03-31 09430446 core:ShareCapital 2023-03-31 09430446 core:SharePremium 2023-03-31 09430446 core:RevaluationReserve 2023-03-31 09430446 core:OtherReservesSubtotal 2023-03-31 09430446 core:RetainedEarningsAccumulatedLosses 2023-03-31 09430446 core:AfterOneYear 2024-04-01 2025-03-31 09430446 core:WithinOneYear 2024-04-01 2025-03-31 09430446 core:Non-currentFinancialInstruments core:CostValuation 2024-04-01 2025-03-31 09430446 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2024-04-01 2025-03-31 09430446 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2024-04-01 2025-03-31 09430446 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2024-04-01 2025-03-31 09430446 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2024-04-01 2025-03-31 09430446 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2024-04-01 2025-03-31 09430446 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2024-04-01 2025-03-31 09430446 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2024-04-01 2025-03-31 09430446 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2024-04-01 2025-03-31 09430446 core:Non-currentFinancialInstruments core:CostValuation 2025-03-31 09430446 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2025-03-31 09430446 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2025-03-31 09430446 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2025-03-31 09430446 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2025-03-31 09430446 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2025-03-31 09430446 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2025-03-31 09430446 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2025-03-31 09430446 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2025-03-31 09430446 core:Non-currentFinancialInstruments core:CostValuation 2024-03-31 09430446 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2024-03-31 09430446 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2024-03-31 09430446 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2024-03-31 09430446 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2024-03-31 09430446 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2024-03-31 09430446 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2024-03-31 09430446 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2024-03-31 09430446 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2024-03-31 09430446 bus:Director1 2024-04-01 2025-03-31

RICHMOND DENTAL SUITE LIMITED

Registered Number
09430446
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

RICHMOND DENTAL SUITE LIMITED
Company Information
for the year from 1 April 2024 to 31 March 2025

Director | Dr Antimos Ouzounoglou

Registered Address | 27 Egerton Road
| Twickenham
| TW2 7SL

Registered Number | 09430446 (England and Wales)

RICHMOND DENTAL SUITE LIMITED
Balance Sheet as at
31 March 2025

| Notes | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £ |  | £ |  | £
Current assets |  |  |  |  |  |  |  |
Debtors |  | 223,545 |  |  |  | 186,986 |  |
|  | 223,545 |  |  |  | 186,986 |  |
Creditors amounts falling due within one year | 3 | (10,860) |  |  |  | (11,005) |  |
Net current assets (liabilities) |  |  |  | 212,685 |  |  |  | 175,981
Total assets less current liabilities |  |  |  | 212,685 |  |  |  | 175,981
Net assets |  |  |  | 212,685 |  |  |  | 175,981
Capital and reserves |  |  |  |  |  |  |  |
Called up share capital |  |  |  | 100 |  |  |  | 100
Profit and loss account |  |  |  | 212,585 |  |  |  | 175,881
Shareholders' funds |  |  |  | 212,685 |  |  |  | 175,981

- The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
- The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
- The Director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
- These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
- The directors have chosen to not file a copy of the company’s profit and loss account under section 444 (5A) Companies Act 2006.

The financial statements were approved and authorised for issue by the Director on 10 March 2026, and are signed on its behalf by:
Dr Antimos Ouzounoglou Director Registered Company No. 09430446

RICHMOND DENTAL SUITE LIMITED
Notes to the Financial Statements
for the year ended 31 March 2025

1. | Accounting policies
--- | ---

| Statutory information
--- | ---
| The company is a private company limited by shares and registered in England and Wales. The company's registered number is 09430446 and registered office address is 27 Egerton Road, Twickenham, England, TW2 7SL.

| Statement of compliance
--- | ---
| The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.

| Basis of preparation
--- | ---
| The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.

| Functional and presentation currency
--- | ---
| The financial statements are presented in sterling and this is the functional currency of the company.

| Going concern
--- | ---
| After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.

| Judgements and key sources of estimation uncertainty
--- | ---
| In the application of the company's accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying values of assets and liabilities that are not readily apparent from other sources. These critical accounting judgements and estimations are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods. The critical judgements made by management that have a significant effect on the amounts recognised in the financial statements are described below.

| Turnover policy
--- | ---
| Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.

| Revenue from rendering of services
--- | ---
| Revenue from the rendering of dental services is recognised by reference to the stage of completion at the reporting date. This is typically determined based on the date the service is performed. For longer-term treatment plans, revenue is recognised based on the proportion of services delivered up to the reporting date, where the outcome can be reliably estimated. Where the outcome of a course of treatment cannot be estimated reliably, revenue is recognised only to the extent that the expenses incurred are recoverable. As the company is not registered for VAT, revenue is stated inclusive of any VAT charged to patients.

| Current taxation
--- | ---
| Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.

| Cash and cash equivalents
--- | ---
| Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less.

| Financial instruments
--- | ---
| A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at transaction price and measured at amortised cost using the effective interest method. Where investments in non-derivative financial instruments are publicly traded, or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value through profit and loss. All other investments are subsequently measured at cost less impairment. Financial assets which are measured at cost or amortised cost are reviewed for objective evidence of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. All equity instruments, regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment.

2. | Average number of employees
--- | ---

|  | 2025 |  | 2024
| Average number of employees during the year | 1 |  | 1

3. | Creditors: amounts due within one year
--- | ---

|  | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £
| Taxation and social security | 8,592 |  | 8,836
| Other creditors | 2,268 |  | 2,169
| Total | 10,860 |  | 11,005

| As at 31 March 2025, other creditors comprise the following: Accruals £ 2,268.00 (2024 :£ 2,169.00)

4. | Share capital
--- | ---
| As at 31 March 2025, the company’s issued and fully paid share capital consisted of ordinary shares with a nominal value of £1 each, amounting to a total of £100. There were no changes in the issued share capital during the year.

5. | Related party transactions
--- | ---
| As at 31 March 2025, the company had balances with related parties as follows: Richmond Dental suite : £223,545.30 (2024: £186,985.90) All outstanding balances with related parties are unsecured, interest-free, and have no fixed date for repayment. No guarantees have been given or received in respect of these balances.